<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">cardio</journal-id><journal-title-group><journal-title xml:lang="ru">Кардиология</journal-title><trans-title-group xml:lang="en"><trans-title>Kardiologiia</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">0022-9040</issn><issn pub-type="epub">2412-5660</issn><publisher><publisher-name>Kardiomag</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18087/cardio.2021.12.n1757</article-id><article-id custom-type="elpub" pub-id-type="custom">cardio-1757</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>RESEARCH ARTICLES</subject></subj-group></article-categories><title-group><article-title>Краткосрочные и отдаленные результаты чрескожных коронарных вмешательств, выполненных в больнице без отделения кардиохирургии, при поражениях высокого и низкого риска</article-title><trans-title-group xml:lang="en"><trans-title>Short- and long-term outcomes of percutaneous coronary interventions of high-risk vs. low-risk lesions performed at a hospital without an on-site cardiac surgery unit</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1831-182X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Бойраз</surname><given-names>Бедреттин</given-names></name><name name-style="western" xml:lang="en"><surname>Boyraz</surname><given-names>Bedrettin</given-names></name></name-alternatives><bio xml:lang="ru"><p>M.D.</p></bio><bio xml:lang="en"><p>M.D.</p></bio><email xlink:type="simple">bedrettinboyraz@yahoo.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аггул</surname><given-names>Бурcу</given-names></name><name name-style="western" xml:lang="en"><surname>Aggul</surname><given-names>Burcu</given-names></name></name-alternatives><bio xml:lang="ru"><p>M.D.</p></bio><bio xml:lang="en"><p>M.D.</p></bio><email xlink:type="simple">burcuakyol1913@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Эртюрк</surname><given-names>Эмре</given-names></name><name name-style="western" xml:lang="en"><surname>Erturk</surname><given-names>Emre</given-names></name></name-alternatives><bio xml:lang="ru"><p>M.D.</p></bio><bio xml:lang="en"><p>M.D.</p></bio><email xlink:type="simple">emre.erturk@ieu.edu.tr</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ибисоглу</surname><given-names>Эрсин</given-names></name><name name-style="western" xml:lang="en"><surname>Ibisoglu</surname><given-names>Ersin</given-names></name></name-alternatives><bio xml:lang="ru"><p>M.D.</p></bio><bio xml:lang="en"><p>M.D.</p></bio><email xlink:type="simple">e_ibisoglu@hotmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Аслан</surname><given-names>Бурхан</given-names></name><name name-style="western" xml:lang="en"><surname>Aslan</surname><given-names>Burhan</given-names></name></name-alternatives><bio xml:lang="ru"><p>M.D.</p></bio><bio xml:lang="en"><p>M.D.</p></bio><email xlink:type="simple">burhanaslndr@gmail.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Битлис-Татванская государственная больница, отделение кардиологии, Битлис, Турция</institution><country>Турция</country></aff><aff xml:lang="en"><institution>Bitlis-Tatvan State Hospital, Cardiology Department, Bitlis, Turkey</institution><country>Turkey</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Измирский экономический университет, больница Medicalpark, кардиологическое отделение, Измир, Турция</institution><country>Турция</country></aff><aff xml:lang="en"><institution>Izmır University of Economics, Medicalpark Hospital, Cardiology Department, Izmir, Turkey</institution><country>Turkey</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Башакшехир Кам и городская больница Сакура, кардиологическое отделение, Стамбул, Турция</institution><country>Турция</country></aff><aff xml:lang="en"><institution>Basaksehir Cam and Sakura City Hospital, Cardiology Department, Istanbul, Turkey</institution><country>Turkey</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Университет медицинских наук, Образовательная и исследовательская больница Диярбакыр Гази Ясаргил, отделение кардиологии, Диярбакыр, Турция</institution><country>Турция</country></aff><aff xml:lang="en"><institution>Health Science University, Diyarbakir Gazi Yasargil Education and Research Hospital, Cardiology Department, Diyarbakir, Turkey</institution><country>Turkey</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>31</day><month>12</month><year>2021</year></pub-date><volume>61</volume><issue>12</issue><fpage>66</fpage><lpage>71</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kardiomag, 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Kardiomag</copyright-holder><copyright-holder xml:lang="en">Kardiomag</copyright-holder><license xlink:href="https://cardio.elpub.ru/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://cardio.elpub.ru/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://cardio.elpub.ru/jour/article/view/1757">https://cardio.elpub.ru/jour/article/view/1757</self-uri><abstract><p>Цель    Широкое применение технологий привело к строительству все большего числа учреждений, имеющих оборудование для проведения коронарной ангиографии с возможностью осуществления чрескожных коронарных вмешательств (ЧКВ). В некоторых из этих центров нет отделений сердечно-сосудистой хирургии (ССХ). В таких больницах также проводились исследования эффективности и безопасности ЧКВ. Однако до настоящего времени процедуры с высоким риском в этом контексте не оценивались. В настоящем исследовании сравниваются результаты ЧКВ, выполненных в группах пациентов с высоким и низким риском, в центрах без возможности оказания кардиохирургической помощи.Материал и методы    В это исследование было включено 999 пациентов, подвергшихся процедуре ЧКВ, исключая больных с диагностированным инфарктом миокарда с подъемом сегмента ST. Пациенты, у которых число баллов по шкале SYNTAX составляло 22 или выше, а также при наличии бифуркационных поражений, хронических тотальных окклюзий, поражений левой коронарной артерии и поражений венозного шунта были отнесены к группе высокого риска. Напротив, пациенты с показателем SYNTAX ниже 22 баллов были включены в группу низкого риска. Коронарные поражения были классифицированы по типам - A, B и C. Производилось сравнение частоты регистрации 30-дневных серьезных неблагоприятные сердечно-сосудистых событий (MACE) и повторных вмешательств на той же артерии в течение 1 года, так называемой реваскуляризации целевого сосуда (РЦС).Результаты    Не установлено существенной разницы между группами в отношении показателей MACE (2 (0,9%) против 5 (0,6%); p=0,64) и РЦС (9 (4,2%) против 25 (3,2%); p=0,52). Анализ типа поражения (A, B, C) также не выявил значимой разницы между показателями MACE и РЦС (p=0,56 и p=0,43, соответственно).Выводы    Результаты этого исследования продемонстрировали, что, как и процедуры с низким риском, сложные коронарные вмешательства с высоким риском могут безопасно и эффективно проводиться в больницах без отделения сердечно-сосудистой хирургии.</p></abstract><trans-abstract xml:lang="en"><p>Aim    Widespread utilization of technology has led to the construction of a growing number of facilities with coronary angiography units and percutaneous coronary intervention (PCI) capability. Some of these centers do not have cardiovascular surgery (CVS) on site. Studies regarding the efficacy and safety of PCIs performed at these hospitals have been conducted. However, to date, high-risk procedures in this context have not been evaluated. The present study compares the outcomes of PCI procedures performed on high- and low-risk lesions groups in a center without CVS back-up.Material and methods    A total of 999 patients treated with PCI with diagnoses other than ST elevation myocardial infarction were included in this study. Patients with SYNTAX scores 22 or higher, bifurcation lesions, chronic total occlusions, left main coronary artery lesions and saphenous graft lesions were classified as a high-risk group. In contrast, patients with SYNTAX scores lower than 22 were included in the low-risk group. Coronary lesions were classified as Type-A, B, and C. The 30‑day major adverse cardiac events (MACE) and 1‑year target vessel revascularization (TVR) rates were compared.Results    There was no significant difference between the groups in terms of the rates of MACE (2 (0.9 %) vs 5 (0.6 %); p=0.64) and TVR (9 (4.2 %) vs 25 (3.2 %); p=0.52). Analysis regarding the lesion type also revealed no significant difference between the MACE and TVR rates (p=0.56 and p=0.43, respectively).Conclusions    The findings in this study demonstrated that, similar to low-risk procedures, complex and high-risk coronary interventions can safely and effectively be conducted in hospitals without a CVS unit.</p><p> </p></trans-abstract><kwd-group xml:lang="ru"><kwd>Ишемическая болезнь сердца</kwd><kwd>чрескожное коронарное вмешательство</kwd><kwd>инфаркт миокарда без подъема сегмента ST</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Coronary artery disease</kwd><kwd>percutaneous coronary intervention</kwd><kwd>non-ST-elevated myocardial infarction</kwd></kwd-group><funding-group><funding-statement xml:lang="ru">Конфликт интересов не заявлен.</funding-statement><funding-statement xml:lang="en">No conflict of interest is reported.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119– 77. DOI: 10.1093/eurheartj/ehx393</mixed-citation><mixed-citation xml:lang="en">Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal. 2018;39(2):119– 77. DOI: 10.1093/eurheartj/ehx393</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/ AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016;134(10):e123–55. DOI: 10.1161/CIR.0000000000000404</mixed-citation><mixed-citation xml:lang="en">Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA et al. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/ AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/ AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation. 2016;134(10):e123–55. DOI: 10.1161/CIR.0000000000000404</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394</mixed-citation><mixed-citation xml:lang="en">Neumann F-J, Sousa-Uva M, Ahlsson A, Alfonso F, Banning AP, Benedetto U et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal. 2019;40(2):87–165. DOI: 10.1093/eurheartj/ehy394</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ et al. SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without OnSite Surgical Backup. Circulation. 2014;129(24):2610–26. DOI: 10.1161/CIR.0000000000000037</mixed-citation><mixed-citation xml:lang="en">Dehmer GJ, Blankenship JC, Cilingiroglu M, Dwyer JG, Feldman DN, Gardner TJ et al. SCAI/ACC/AHA Expert Consensus Document: 2014 Update on Percutaneous Coronary Intervention Without OnSite Surgical Backup. Circulation. 2014;129(24):2610–26. DOI: 10.1161/CIR.0000000000000037</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–609. DOI: 10.1161/CIR.0b013e31823a5596</mixed-citation><mixed-citation xml:lang="en">Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B et al. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;124(23):2574–609. DOI: 10.1161/CIR.0b013e31823a5596</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Jacobs AK, Normand S-LT, Massaro JM, Cutlip DE, Carrozza JP, Marks AD et al. Nonemergency PCI at Hospitals with or without On-Site Cardiac Surgery. New England Journal of Medicine. 2013;368(16):1498–508. DOI: 10.1056/NEJMoa1300610</mixed-citation><mixed-citation xml:lang="en">Jacobs AK, Normand S-LT, Massaro JM, Cutlip DE, Carrozza JP, Marks AD et al. Nonemergency PCI at Hospitals with or without On-Site Cardiac Surgery. New England Journal of Medicine. 2013;368(16):1498–508. DOI: 10.1056/NEJMoa1300610</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Aversano T, Lemmon CC, Liu L. Outcomes of PCI at Hospitals with or without On-Site Cardiac Surgery. New England Journal of Medicine. 2012;366(19):1792–802. DOI: 10.1056/NEJMoa1114540</mixed-citation><mixed-citation xml:lang="en">Aversano T, Lemmon CC, Liu L. Outcomes of PCI at Hospitals with or without On-Site Cardiac Surgery. New England Journal of Medicine. 2012;366(19):1792–802. DOI: 10.1056/NEJMoa1114540</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Thuijs DJFM, Kappetein AP, Serruys PW, Mohr F-W, Morice M-C, Mack MJ et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet. 2019;394(10206):1325–34. DOI: 10.1016/S0140-6736(19)31997-X</mixed-citation><mixed-citation xml:lang="en">Thuijs DJFM, Kappetein AP, Serruys PW, Mohr F-W, Morice M-C, Mack MJ et al. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial. The Lancet. 2019;394(10206):1325–34. DOI: 10.1016/S0140-6736(19)31997-X</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Ikeno F, Brooks MM, Nakagawa K, Kim M-K, Kaneda H, Mitsutake Y et al. SYNTAX Score and Long-Term : The BARI-2D Trial. Journal of the American College of Cardiology. 2017;69(4):395–403. DOI: 10.1016/j.jacc.2016.10.067</mixed-citation><mixed-citation xml:lang="en">Ikeno F, Brooks MM, Nakagawa K, Kim M-K, Kaneda H, Mitsutake Y et al. SYNTAX Score and Long-Term : The BARI-2D Trial. Journal of the American College of Cardiology. 2017;69(4):395–403. DOI: 10.1016/j.jacc.2016.10.067</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McCallister BD et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88(6):2987–3007. DOI: 10.1161/01.CIR.88.6.2987</mixed-citation><mixed-citation xml:lang="en">Ryan TJ, Bauman WB, Kennedy JW, Kereiakes DJ, King SB, McCallister BD et al. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty). Circulation. 1993;88(6):2987–3007. DOI: 10.1161/01.CIR.88.6.2987</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Steinberg DH, Mishra S, Javaid A, Slottow TLP, Buch AN, Roy P et al. Comparison of Effectiveness of Bare Metal Stents Versus DrugEluting Stents in Large (≥3.5 mm) Coronary Arteries. The American Journal of Cardiology. 2007;99(5):599–602. DOI: 10.1016/j.amjcard.2006.09.105</mixed-citation><mixed-citation xml:lang="en">Steinberg DH, Mishra S, Javaid A, Slottow TLP, Buch AN, Roy P et al. Comparison of Effectiveness of Bare Metal Stents Versus DrugEluting Stents in Large (≥3.5 mm) Coronary Arteries. The American Journal of Cardiology. 2007;99(5):599–602. DOI: 10.1016/j.amjcard.2006.09.105</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Changal KH, Mir T, Khan S, Nazir S, Elzanatey A, Meenakshisundaram C et al. Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine. 2021;23:42–9. DOI: 10.1016/j.carrev.2020.07.018</mixed-citation><mixed-citation xml:lang="en">Changal KH, Mir T, Khan S, Nazir S, Elzanatey A, Meenakshisundaram C et al. Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis. Cardiovascular Revascularization Medicine. 2021;23:42–9. DOI: 10.1016/j.carrev.2020.07.018</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
